|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product and service revenue | |||||
| Product revenue | |||||
| Service revenue | |||||
| Contract revenue | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Product revenue | |||||
| Service revenue | |||||
| Contract revenue | |||||
| Total cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Change in fair value of contingent consideration | |||||
| Goodwill impairment | |||||
| Total operating expenses | |||||
| Loss from continuing operations | |||||
| Other income, net: | |||||
| Interest income | |||||
| Interest expense | |||||
| Income from transition services agreement, net | |||||
| Other expense, net | |||||
| Total other income, net | |||||
| Loss from operations before income taxes | |||||
| Income tax expense | |||||
| Net loss from continuing operations | |||||
| Net income (loss) from discontinued operations, net of tax | |||||
| Net income (loss) attributable to common stockholders | |||||
| Net loss from continuing operations per share attributable to common stockholders, basic | |||||
| Net loss from continuing operations per share attributable to common stockholders, diluted | |||||
| Net income (loss) from discontinued operations per share attributable to common stockholders, basic | |||||
| Net income (loss) from discontinued operations per share attributable to common stockholders, diluted | |||||
| Net income (loss) per share attributable to common stockholders, basic | |||||
| Net income (loss) per share attributable to common stockholders, diluted | |||||
| Weighted average common shares outstanding, basic | |||||
| Weighted average common shares outstanding, diluted | |||||
Loading...